Lucas Research is an independent clinical research site located on the coast of North Carolina, founded in 2004. Led by Dr. K Jean Lucas, a Board Certified Endocrinologist and Internist, the 23,000 square foot, state-of-the-art facility is home to a 50+ member team, including Principal Investigators, Sub-Investigators, and Clinical Research Coordinators. Specializing in Diabetes, NASH, Diabetic Nephropathy, Thyroid, High Triglyceride, CV Outcome, and Obesity trials, Lucas Research consistently ranks as a top enroller globally. The company is committed to pushing medicine forward by leading in clinical research to improve lives globally by serving locally. Currently, they are seeking new clinical trial opportunities in various health areas including diabetes, arthritis, cirrhosis, continuous glucose monitoring, Crohn's disease, and many more. With a focus on healthcare, headquartered in the United States, Lucas Research presents an opportunity for venture capitalists to invest in the forefront of medical research and innovation.
There is no investment information
No recent news or press coverage available for Lucas Research.